FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1415-1417 November 23, 1995 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Guillain–Barré syndrome^1,2 is a leading cause of acute paralysis. It occurs worldwide, in patients of all ages and both sexes. The weakness develops in a matter of days, sometimes with frightening rapidity and severity. Thirty percent of patients require treatment in critical care units, where ingenuity and resources are taxed to their maximum, and the stress on the patient and family is enormous. Nonetheless, modern management has reduced the mortality rate from 30 to 3 percent, and 75 percent of patients recover completely in 6 to 12 months.

Guillain–Barré syndrome has traditionally been regarded as a poorly understood immune-mediated attack . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lo, Y.-L., Mills, K. R (1999). Motor root conduction in neuralgic amyotrophy: evidence of proximal conduction block. J. Neurol. Neurosurg. Psychiatry 66: 586-590 [Abstract] [Full Text]  
• Gominak, S. C., Cros, D. P. (1998). Case 13-1998- A 23-Year-Old Man with Progressive Weakness and Paresthesias. NEJM 338: 1212-1219 [Full Text]